Related Experiment Video
Updated: Jun 7, 2026

Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases
Deviprasad R Gollapalli1, Iain S Macpherson, George Liechti
1Department of Biology, Brandeis University, 415 South Street, Waltham, MA 02454-9110, USA.
Abstract:
The protozoan parasite Cryptosporidium parvum is a major cause of gastrointestinal disease; no effective drug therapy exists to treat this infection. Curiously, C. parvum IMPDH (CpIMPDH) is most closely related to prokaryotic IMPDHs, suggesting that the parasite obtained its IMPDH gene via horizontal transfer. We previously identified inhibitors of CpIMPDH that do not inhibit human IMPDHs. Here, we show that these compounds also inhibit IMPDHs from Helicobacter pylori, Borrelia burgdorferi, and Streptococcus pyogenes, but not from Escherichia coli. Residues Ala165 and Tyr358 comprise a structural motif that defines susceptible enzymes. Importantly, a second-generation CpIMPDH inhibitor has bacteriocidal activity on H. pylori but not E. coli. We propose that CpIMPDH-targeted inhibitors can be developed into a new class of antibiotics that will spare some commensal bacteria.
Insights
New drug candidates targeting Cryptosporidium parvum inosine monophosphate dehydrogenase (CpIMPDH) show promise as novel antibiotics. These inhibitors are effective against various bacterial IMPDHs, sparing beneficial gut bacteria.
Area of Science:
- Parasitology
- Microbiology
- Drug Discovery
Background:
- Cryptosporidium parvum causes significant gastrointestinal illness with no effective treatments.
- CpIMPDH exhibits close homology to prokaryotic IMPDHs, suggesting horizontal gene transfer.
- Existing CpIMPDH inhibitors do not affect human IMPDH, indicating target specificity.
Purpose of the Study:
- To investigate the potential of CpIMPDH inhibitors as broad-spectrum antibacterial agents.
- To identify structural features of IMPDH enzymes conferring susceptibility to inhibitors.
- To evaluate the therapeutic potential of second-generation inhibitors against specific bacterial pathogens.
Main Methods:
- Enzyme inhibition assays using CpIMPDH and IMPDH from various bacterial species (H. pylori, B. burgdorferi, S. pyogenes, E. coli).
- Structural analysis to identify key residues (Ala165, Tyr358) in susceptible IMPDH enzymes.
- Bactericidal activity assays of a second-generation CpIMPDH inhibitor against H. pylori and E. coli.
Main Results:
- CpIMPDH inhibitors demonstrated activity against IMPDH from H. pylori, B. burgdorferi, and S. pyogenes, but not E. coli.
- A conserved structural motif (Ala165, Tyr358) was identified as critical for enzyme susceptibility.
- A second-generation inhibitor exhibited bactericidal effects on H. pylori without harming E. coli.
Conclusions:
- CpIMPDH-targeted inhibitors represent a promising new class of antibiotics.
- These compounds show selective activity against pathogenic bacteria, potentially sparing commensal flora.
- Further development could lead to novel therapeutic strategies for parasitic and bacterial infections.
Related Concept Videos
Enzyme Inhibition
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of Bacterial Protein Synthesis
Ligand Binding and Linkage

